The role of combination therapy with antiplatelet and oral anticoagulant agents in cardiovascular disease

Research output: Contribution to journalReview article

Abstract

This review examines the use of combinations of oral antiplatelet agents with oral anticoagulant agents for long-term secondary prevention in patients with cardiovascular diseases such as myocardial infarction (MI), mechanical valve replacement, coronary artery stent implantation, and chronic atrial fibrillation (AF).

Original languageEnglish
Pages (from-to)561-562+565
JournalP and T
Volume26
Issue number11
StatePublished - 2001

Fingerprint

Platelet Aggregation Inhibitors
Secondary Prevention
Anticoagulants
Atrial Fibrillation
Stents
Coronary Vessels
Cardiovascular Diseases
Myocardial Infarction
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

The role of combination therapy with antiplatelet and oral anticoagulant agents in cardiovascular disease. / Lenz, Thomas L.; Hilleman, Daniel E.

In: P and T, Vol. 26, No. 11, 2001, p. 561-562+565.

Research output: Contribution to journalReview article

@article{63809ed02d2a4914aae18f5211c2f273,
title = "The role of combination therapy with antiplatelet and oral anticoagulant agents in cardiovascular disease",
abstract = "This review examines the use of combinations of oral antiplatelet agents with oral anticoagulant agents for long-term secondary prevention in patients with cardiovascular diseases such as myocardial infarction (MI), mechanical valve replacement, coronary artery stent implantation, and chronic atrial fibrillation (AF).",
author = "Lenz, {Thomas L.} and Hilleman, {Daniel E.}",
year = "2001",
language = "English",
volume = "26",
pages = "561--562+565",
journal = "P and T",
issn = "1052-1372",
publisher = "MediMedia USA Inc.",
number = "11",

}

TY - JOUR

T1 - The role of combination therapy with antiplatelet and oral anticoagulant agents in cardiovascular disease

AU - Lenz, Thomas L.

AU - Hilleman, Daniel E.

PY - 2001

Y1 - 2001

N2 - This review examines the use of combinations of oral antiplatelet agents with oral anticoagulant agents for long-term secondary prevention in patients with cardiovascular diseases such as myocardial infarction (MI), mechanical valve replacement, coronary artery stent implantation, and chronic atrial fibrillation (AF).

AB - This review examines the use of combinations of oral antiplatelet agents with oral anticoagulant agents for long-term secondary prevention in patients with cardiovascular diseases such as myocardial infarction (MI), mechanical valve replacement, coronary artery stent implantation, and chronic atrial fibrillation (AF).

UR - http://www.scopus.com/inward/record.url?scp=0035188477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035188477&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0035188477

VL - 26

SP - 561-562+565

JO - P and T

JF - P and T

SN - 1052-1372

IS - 11

ER -